Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy
Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy Dan Ziegler , MD 1 , Christoph G.H. Sohr , CAND MED 1 and Jaffar Nourooz-Zadeh , PHD 2 1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine Unive...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2004-09, Vol.27 (9), p.2178-2183 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2183 |
---|---|
container_issue | 9 |
container_start_page | 2178 |
container_title | Diabetes care |
container_volume | 27 |
creator | ZIEGLER, Dan SOHR, Christoph G. H NOUROOZ-ZADEH, Jaffar |
description | Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic
Neuropathy
Dan Ziegler , MD 1 ,
Christoph G.H. Sohr , CAND MED 1 and
Jaffar Nourooz-Zadeh , PHD 2
1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany
2 Department of Medicine, University College Medical School, London, U.K
Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität,
Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de
Abstract
OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated
in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various
biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular
autonomic neuropathy (CAN).
RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85).
RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased
in the PN + /CAN − group compared with the control group (all P < 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P < 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P < 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent
determinants.
CONCLUSIONS —Oxidative stress is enhanced in diabetic patients |
doi_str_mv | 10.2337/diacare.27.9.2178 |
format | Article |
fullrecord | <record><control><sourceid>gale_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_16081820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A122532059</galeid><sourcerecordid>A122532059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</originalsourceid><addsrcrecordid>eNqFkluLEzEYhgdR3Fr9Ad5IEPRCmJrDZA6XpesJFlc8XA_fTL60WaZJN8lU-wv826bbwQUpSC4CyfN-xzfLnjO64EJUb5WBHjwueLVoFpxV9YNsxhohcymL-mE2o6xoctk0_CJ7EsINpbQo6vpxdsGkEKKo2Sz7ff3LKIhmj-Rb9BgCAavI0kbjjh82kkvUaAMSY8lXHBLqLImOxE1S4B69iQfiNLk00GE0PfnihoPF0bsdxM3hLtwKvDJuD6EfB_BkOUZn3Taxn_9yT7NHGoaAz6Z7nv14_-776mN-df3h02p5lfeyFDHvoQaue62oakSHpdZVp6UokdYVlryqWad4l1puKiUargBkxwBUWcqa1R2Iefb6FHfn3e2IIbZbE3ocBrDoxtCWZc15QYv_gqxJFGVVAl_-A9640dvURMu5oIVs0krmWX6C1jBga6x20UO_RoseBmdRm_S8ZJxLwak88oszfDoK09zOCthJ0HsXgkfd7rzZgj-0jLZHs7STWVpetU17NEvSvJgqH7stqnvF5I4EvJqAtDoYtAfbm3DPlTQNldPEvTlxG7Pe_DQpibpzA4YzWf8AjujZtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223045919</pqid></control><display><type>article</type><title>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>ZIEGLER, Dan ; SOHR, Christoph G. H ; NOUROOZ-ZADEH, Jaffar</creator><creatorcontrib>ZIEGLER, Dan ; SOHR, Christoph G. H ; NOUROOZ-ZADEH, Jaffar</creatorcontrib><description>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic
Neuropathy
Dan Ziegler , MD 1 ,
Christoph G.H. Sohr , CAND MED 1 and
Jaffar Nourooz-Zadeh , PHD 2
1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany
2 Department of Medicine, University College Medical School, London, U.K
Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität,
Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de
Abstract
OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated
in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various
biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular
autonomic neuropathy (CAN).
RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85).
RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased
in the PN + /CAN − group compared with the control group (all P < 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P < 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P < 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent
determinants.
CONCLUSIONS —Oxidative stress is enhanced in diabetic patients before the development of PN but to an even higher degree in those with
PN, without further significant increase in relation to superimposed autonomic neuropathy. However, apart from oxidative stress,
diabetes duration and triglyceride levels are also related to the severity of PN.
CAN, cardiovascular autonomic neuropathy
MNCV, motor nerve conduction velocity
NIS-LL, Neuropathy Impairment Score of the Lower Limbs
O2·−, superoxide anion
ONOO−, peroxynitrite
PGF, prostaglandin F
PN, polyneuropathy
SIN-1, 3-morpholino-sydnonimine HCl
TPT, thermal perception threshold
VPT, vibration perception threshold
Footnotes
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Accepted June 15, 2004.
Received January 12, 2004.
DIABETES CARE</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.27.9.2178</identifier><identifier>PMID: 15333481</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Adult ; Antioxidants ; Antioxidants - metabolism ; Ascorbic Acid - blood ; Autonomic Nervous System Diseases - blood ; Autonomic Nervous System Diseases - physiopathology ; Autonomic neuropathies ; Biological and medical sciences ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - physiopathology ; Care and treatment ; Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction ; Diabetes ; Diabetes. Impaired glucose tolerance ; Diabetic Neuropathies - blood ; Diabetic Neuropathies - physiopathology ; Diabetics ; Diagnosis ; Dinoprost - analogs & derivatives ; Dinoprost - blood ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Female ; Free radicals ; Humans ; Male ; Medical sciences ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurological disorders ; Neurology ; Oxidative Stress - physiology ; Reference Values</subject><ispartof>Diabetes care, 2004-09, Vol.27 (9), p.2178-2183</ispartof><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 American Diabetes Association</rights><rights>Copyright American Diabetes Association Sep 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</citedby><cites>FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16081820$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15333481$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZIEGLER, Dan</creatorcontrib><creatorcontrib>SOHR, Christoph G. H</creatorcontrib><creatorcontrib>NOUROOZ-ZADEH, Jaffar</creatorcontrib><title>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic
Neuropathy
Dan Ziegler , MD 1 ,
Christoph G.H. Sohr , CAND MED 1 and
Jaffar Nourooz-Zadeh , PHD 2
1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany
2 Department of Medicine, University College Medical School, London, U.K
Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität,
Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de
Abstract
OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated
in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various
biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular
autonomic neuropathy (CAN).
RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85).
RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased
in the PN + /CAN − group compared with the control group (all P < 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P < 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P < 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent
determinants.
CONCLUSIONS —Oxidative stress is enhanced in diabetic patients before the development of PN but to an even higher degree in those with
PN, without further significant increase in relation to superimposed autonomic neuropathy. However, apart from oxidative stress,
diabetes duration and triglyceride levels are also related to the severity of PN.
CAN, cardiovascular autonomic neuropathy
MNCV, motor nerve conduction velocity
NIS-LL, Neuropathy Impairment Score of the Lower Limbs
O2·−, superoxide anion
ONOO−, peroxynitrite
PGF, prostaglandin F
PN, polyneuropathy
SIN-1, 3-morpholino-sydnonimine HCl
TPT, thermal perception threshold
VPT, vibration perception threshold
Footnotes
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Accepted June 15, 2004.
Received January 12, 2004.
DIABETES CARE</description><subject>Adult</subject><subject>Antioxidants</subject><subject>Antioxidants - metabolism</subject><subject>Ascorbic Acid - blood</subject><subject>Autonomic Nervous System Diseases - blood</subject><subject>Autonomic Nervous System Diseases - physiopathology</subject><subject>Autonomic neuropathies</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Care and treatment</subject><subject>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</subject><subject>Diabetes</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic Neuropathies - blood</subject><subject>Diabetic Neuropathies - physiopathology</subject><subject>Diabetics</subject><subject>Diagnosis</subject><subject>Dinoprost - analogs & derivatives</subject><subject>Dinoprost - blood</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Free radicals</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurological disorders</subject><subject>Neurology</subject><subject>Oxidative Stress - physiology</subject><subject>Reference Values</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkluLEzEYhgdR3Fr9Ad5IEPRCmJrDZA6XpesJFlc8XA_fTL60WaZJN8lU-wv826bbwQUpSC4CyfN-xzfLnjO64EJUb5WBHjwueLVoFpxV9YNsxhohcymL-mE2o6xoctk0_CJ7EsINpbQo6vpxdsGkEKKo2Sz7ff3LKIhmj-Rb9BgCAavI0kbjjh82kkvUaAMSY8lXHBLqLImOxE1S4B69iQfiNLk00GE0PfnihoPF0bsdxM3hLtwKvDJuD6EfB_BkOUZn3Taxn_9yT7NHGoaAz6Z7nv14_-776mN-df3h02p5lfeyFDHvoQaue62oakSHpdZVp6UokdYVlryqWad4l1puKiUargBkxwBUWcqa1R2Iefb6FHfn3e2IIbZbE3ocBrDoxtCWZc15QYv_gqxJFGVVAl_-A9640dvURMu5oIVs0krmWX6C1jBga6x20UO_RoseBmdRm_S8ZJxLwak88oszfDoK09zOCthJ0HsXgkfd7rzZgj-0jLZHs7STWVpetU17NEvSvJgqH7stqnvF5I4EvJqAtDoYtAfbm3DPlTQNldPEvTlxG7Pe_DQpibpzA4YzWf8AjujZtw</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>ZIEGLER, Dan</creator><creator>SOHR, Christoph G. H</creator><creator>NOUROOZ-ZADEH, Jaffar</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</title><author>ZIEGLER, Dan ; SOHR, Christoph G. H ; NOUROOZ-ZADEH, Jaffar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Antioxidants</topic><topic>Antioxidants - metabolism</topic><topic>Ascorbic Acid - blood</topic><topic>Autonomic Nervous System Diseases - blood</topic><topic>Autonomic Nervous System Diseases - physiopathology</topic><topic>Autonomic neuropathies</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Care and treatment</topic><topic>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</topic><topic>Diabetes</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic Neuropathies - blood</topic><topic>Diabetic Neuropathies - physiopathology</topic><topic>Diabetics</topic><topic>Diagnosis</topic><topic>Dinoprost - analogs & derivatives</topic><topic>Dinoprost - blood</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Free radicals</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurological disorders</topic><topic>Neurology</topic><topic>Oxidative Stress - physiology</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZIEGLER, Dan</creatorcontrib><creatorcontrib>SOHR, Christoph G. H</creatorcontrib><creatorcontrib>NOUROOZ-ZADEH, Jaffar</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Agriculture Science Database</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>ProQuest Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZIEGLER, Dan</au><au>SOHR, Christoph G. H</au><au>NOUROOZ-ZADEH, Jaffar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>27</volume><issue>9</issue><spage>2178</spage><epage>2183</epage><pages>2178-2183</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic
Neuropathy
Dan Ziegler , MD 1 ,
Christoph G.H. Sohr , CAND MED 1 and
Jaffar Nourooz-Zadeh , PHD 2
1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany
2 Department of Medicine, University College Medical School, London, U.K
Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität,
Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de
Abstract
OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated
in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various
biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular
autonomic neuropathy (CAN).
RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85).
RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased
in the PN + /CAN − group compared with the control group (all P < 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P < 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P < 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent
determinants.
CONCLUSIONS —Oxidative stress is enhanced in diabetic patients before the development of PN but to an even higher degree in those with
PN, without further significant increase in relation to superimposed autonomic neuropathy. However, apart from oxidative stress,
diabetes duration and triglyceride levels are also related to the severity of PN.
CAN, cardiovascular autonomic neuropathy
MNCV, motor nerve conduction velocity
NIS-LL, Neuropathy Impairment Score of the Lower Limbs
O2·−, superoxide anion
ONOO−, peroxynitrite
PGF, prostaglandin F
PN, polyneuropathy
SIN-1, 3-morpholino-sydnonimine HCl
TPT, thermal perception threshold
VPT, vibration perception threshold
Footnotes
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Accepted June 15, 2004.
Received January 12, 2004.
DIABETES CARE</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>15333481</pmid><doi>10.2337/diacare.27.9.2178</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-5992 |
ispartof | Diabetes care, 2004-09, Vol.27 (9), p.2178-2183 |
issn | 0149-5992 1935-5548 |
language | eng |
recordid | cdi_pascalfrancis_primary_16081820 |
source | MEDLINE; Free E-Journal (出版社公開部分のみ) |
subjects | Adult Antioxidants Antioxidants - metabolism Ascorbic Acid - blood Autonomic Nervous System Diseases - blood Autonomic Nervous System Diseases - physiopathology Autonomic neuropathies Biological and medical sciences Cardiovascular Diseases - blood Cardiovascular Diseases - physiopathology Care and treatment Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction Diabetes Diabetes. Impaired glucose tolerance Diabetic Neuropathies - blood Diabetic Neuropathies - physiopathology Diabetics Diagnosis Dinoprost - analogs & derivatives Dinoprost - blood Endocrine pancreas. Apud cells (diseases) Endocrinopathies Female Free radicals Humans Male Medical sciences Middle Aged Nervous system (semeiology, syndromes) Neurological disorders Neurology Oxidative Stress - physiology Reference Values |
title | Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T19%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxidative%20Stress%20and%20Antioxidant%20Defense%20in%20Relation%20to%20the%20Severity%20of%20Diabetic%20Polyneuropathy%20and%20Cardiovascular%20Autonomic%20Neuropathy&rft.jtitle=Diabetes%20care&rft.au=ZIEGLER,%20Dan&rft.date=2004-09-01&rft.volume=27&rft.issue=9&rft.spage=2178&rft.epage=2183&rft.pages=2178-2183&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.27.9.2178&rft_dat=%3Cgale_pasca%3EA122532059%3C/gale_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223045919&rft_id=info:pmid/15333481&rft_galeid=A122532059&rfr_iscdi=true |